International Graduates Face Rising Hurdles in US Job Market The American Dream Is Collapsing
ASML Holding NV Gains Attention as Key Tech Holding in Billionaire Ken Fishers Portfolio Goldman Sachs Lifts Price Target
Prediction Markets Signal Rising Odds of Fed Rate Hike by July 2027
Innospec IOSP Among Notable Small Cap Stocks as Company Boosts Dividend and Launches Share Repurchase
Market Speculates on Timeline for Potential Shift Away from Quarterly Earnings Reports
Beyond Inc to Reunite Buy Buy Baby with Bed Bath Beyond After Brand Rights Acquisition
INVH Q1 2026 Earnings Strong EPS Surprise Amidst Stable Operations
CIG Q1 2026 Earnings EPS Beats Estimates by 1247 Shares Edge Lower
HOV Q1 2026 Earnings Surprise EPS Beat Amid Challenging Housing Market
XENE Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances
IBP Q1 2026 Earnings Earnings Miss Prediction Despite Positive Stock Reaction
MYE Q1 2026 Earnings Strong Earnings Beat as Profitability Surges Past Estimates
Pagaya Technologies Warrants PGYWW Struggle Near Par as Price Holds at 005
RGA Stock Slides 09 as Reinsurance Sector Faces Headwinds Key Levels in Focus
Cloudastructure CSAI Rallies Slightly Approaches Key Resistance at 050
Rain Enhancement Technologies RAIN Surges 6 as Momentum Builds Near Resistance
Qwest Corporation 65 Notes CTBB Edge Higher Amid Steady Income Demand
BJs Wholesale to Implement Major Store Changes Amid Consumer Spending Pullback
CLRB Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Sentiment
Myseum Inc MYSE Gains 176 as Price Approaches Resistance Near 182
Safeguard Acquisition Corp SAC Edges Higher Nearing Resistance Level
Oric Pharmaceuticals ORIC Holds Steady Near Key Support Levels Amidst Modest Gains
TAT Technologies Ltd TATT Surges 325 as Shares Test Key Resistance Near 4033
EXG Inches Higher as Global Diversified Income Fund Trades Near Midpoint of Range
Alamo Group ALG Climbs 171 as Shares Approach Key Resistance
Camping World Holdings CWH Extends Decline as Recreational Vehicle Demand Remains Under Pressure
ABVC BioPharma Consolidates at 139 as Support and Resistance Levels Narrow